Embolic Protection Devices Market Status (2016-2020) and Forecast Market Analysis, Regional Outlook, Segment Growth Potential, and Competitive Market Share Analysis, 2021-2027
Report Description
The global Embolic Protection Devices market size is estimated at USD 980.4 million in 2020, expanding at a CAGR 8.8% from 2021-2027 to reach 1,400.8 million USD in 2027.
Market Dynamics
Embolic protection devices (EPDs) are the most common type of device used during percutaneous cardiac procedures. The use of embolic protection devices (EPD) during percutaneous cardiac procedures has helped to reduce the number of complications caused by debris entering the bloodstream and clogging smaller vessels. These devices are a component of the most effective, scientifically proven treatment for preventing periprocedural myocardial infarction and other major cardiovascular events. Depending on their mechanism of action, EPDs are classified as distal occlusion aspiration devices, distal filters, or proximal occlusion aspiration devices.
One of the key factors driving the market growth is the rising prevalence of cardiovascular diseases (CVDs). EPDs are critical in reducing complications caused by blockages in small blood vessels caused by debris in the bloodstream. They are a component of the most dependable, evidence-based procedure for lowering periprocedural MI and other major cardiovascular events. This, combined with an increase in cardiac arrests and other heart-related issues, is providing a significant boost to the EPD market. Furthermore, governments around the world are investing in expanding their research and development (R&D) capabilities, which is another major growth-inducing factor.
The world's steadily growing geriatric population, which is more vulnerable to chronic medical illnesses, is also contributing to market growth. Other factors that are expected to contribute to the market's positive outlook include rising demand for minimally invasive products, technological advancements, and significant growth in the healthcare sector.
Regional Insights
Over the course of the study, the market for embolic protection devices in North America will grow by around 10%. The rising prevalence of cardiovascular and neurovascular diseases in the region is a major factor driving the growth of the embolic protection devices market in the coming years. Obesity prevalence, lifestyle patterns, and unhealthy dietary habits will all have a positive impact on regional market growth. The strong foothold of major industry players in North America will further boost the growth of the embolic protection devices industry.
In 2020, the Asia Pacific was growing due to a rapidly aging population, which is predisposed to various neurological, cardiovascular, and other chronic diseases that can be attributed to regional growth. The region's urbanization, changing lifestyle, and rising prevalence of risk factors such as obesity and hypertension will favor segmental growth. Increasing government support and healthcare reforms in countries such as China will drive growth in the Asia Pacific embolic protection devices industry in the coming years.
Segment Insights
The Embolic Protection Devices market is fragmented into product, application, procedure, usage, material and end-user segments. Based on the product, the proximal occlusion systems segment is anticipated to dominate the market. Based on application, the cardiovascular segment is expected to witness the highest CAGR. By material, Nitinol will exhibit substantial growth during the analysis period. By end-user, the hospitals' segment exhibits momentous growth over the forecast timeline.
Competitive Insights
The Embolic Protection Devices market is highly competitive in nature with the presence of local & international players. Major players in the industry engage in strategic mergers & acquisitions, partnerships, and new product launches to remain competent in the market.
The competitive landscape of the industry has also been examined with some of the key players being Abbott Laboratories, Allium Medical Solutions Ltd., Boston Scientific Corporation, Cardinal Health Inc., Contego Medical LLC, Innovative Cardiovascular Solutions LLC, Edwards Lifesciences Corporation, Medtronic Inc., Silk Road Medical Inc., etc.
The report begins with an overview of the Industry Chain structure, and describes the industry environment, then analyses the market size and forecast of Embolic Protection Devices by product, application, procedure, material, usage, end-user, and region. In addition, this report introduces the market competition situation among the vendors, and the company profile, besides, market price analysis, and value chain features are covered in this report.
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
- Abbott Laboratories
- Allium Medical Solutions Ltd.
- Boston Scientific Corporation
- Cardinal Health Inc.
- Contego Medical LLC
- Innovative Cardiovascular Solutions LLC
- Edwards Lifesciences Corporation
- Medtronic Inc.
- Silk Road Medical Inc.
Product Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Non-invasive
- Minimally Invasive
- Topical
Application Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Coronary Artery Treatment
- Carotid Artery Treatment
- Others
Procedure Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Percutaneous Coronary Intervention
- Carotid Artery Stenosis
- Saphenous Vein Graft Intervention
- Aortic Valve Stenosis
- Others
Material Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Nitinol
- Polyurethane
Usage Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Disposable Devices
- Re-Usable Devices
End User Coverage (Market Size & Forecast, Main Consumer Analysis etc.):
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Others
Region Coverage (Regional Consumption, Demand & Forecast by Countries etc.):
- North America (U.S., and Canada)
- Europe (Germany, U.K., France, Italy, Spain etc.)
- Asia-Pacific (China, India, Japan, Indonesia, Malaysia, Australia, South Korea, etc.)
- South America (Brazil, Mexico, Argentina etc.)
- Middle East & Africa (Saudi Arabia, Kuwait, UAE, South Africa etc.)
Table Of Content
1. Embolic Protection Devices Market Overview
1.1. Product Overview and Scope of Embolic Protection Devices
1.2. Global Market Growth Prospects and Revenue Estimates
1.3. Global Embolic Protection Devices Market Size Growth Rate Analysis by Product 2020 VS 2027
1.3.1. Distal Filter Devices
1.3.2. Distal Occlusion Devices
1.3.3. Proximal Occlusion Devices
1.4. Global Embolic Protection Devices Comparison by Application: 2020 VS 2027
1.4.1. Coronary Artery Treatment
1.4.2. Carotid Artery Treatment
1.4.3. Others
1.5. Global Embolic Protection Devices Comparison by Procedure: 2020 VS 2027
1.5.1. Percutaneous Coronary Intervention
1.5.2. Carotid Artery Stenosis
1.5.3. Saphenous Vein Graft Intervention
1.5.4. Aortic Valve Stenosis
1.5.5. Others
1.6. Global Embolic Protection Devices Comparison by Material: 2020 VS 2027
1.6.1. Nitinol
1.6.2. Polyurethane
1.7. Global Embolic Protection Devices Comparison by Usage: 2020 VS 2027
1.7.1. Disposable Devices
1.7.2. Re-Usable Devices
1.8. Global Embolic Protection Devices Comparison by End User: 2020 VS 2027
1.8.1. Hospitals and Clinics
1.8.2. Ambulatory Surgical Centers
1.8.3. Others
1.9. Global Embolic Protection Devices Market Size Estimates and Forecasts by Region: 2020 VS 2027
1.9.1. North America Embolic Protection Devices Estimates
1.9.2. Europe Embolic Protection Devices Estimates
1.9.3. Asia Pacific Embolic Protection Devices Estimates
1.9.4. South America Embolic Protection Devices Estimates
1.9.5. Middle East & Africa Embolic Protection Devices Estimates
2. Market Competition by Manufacturers
2.1. Global Embolic Protection Devices Revenue Market Share by Manufacturers (2020)
2.2. Embolic Protection Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3. Global Embolic Protection Devices Average Price by Manufacturers (2020-2027)
2.4. Manufacturers Embolic Protection Devices Production Sites, Area Served, Product Types
2.5. Embolic Protection Devices Market Competitive Situation and Trends
2.5.1. Embolic Protection Devices Market Concentration Rate
2.5.2. Mergers & Acquisitions, Expansion
3. Global Embolic Protection Devices Consumption by Region (2020-2027)
3.1. Global Embolic Protection Devices Consumption by Region
3.2. Global Embolic Protection Devices Consumption Market Share by Region
3.2.1. North America
3.2.2. North America Embolic Protection Devices Consumption Growth Rate (2020-2027)
3.2.3. North America Embolic Protection Devices Consumption, Price and Gross Margin (2020-2027)
3.2.4. North America Embolic Protection Devices Consumption by Country
3.2.4.1. U.S.
3.2.4.2. Canada
3.2.5. Europe
3.2.6. Europe Embolic Protection Devices Consumption Growth Rate (2020-2027)
3.2.7. Europe Embolic Protection Devices Consumption, Price and Gross Margin (2020-2027)
3.2.8. Europe Embolic Protection Devices Consumption by Country
3.2.8.1. Germany
3.2.8.2. U.K.
3.2.8.3. France
3.2.8.4. Italy
3.2.8.5. Spain
3.2.9. Asia Pacific
3.2.10. Asia Pacific Embolic Protection Devices Consumption Growth Rate (2020-2027)
3.2.11. Asia Pacific Embolic Protection Devices Consumption, Price and Gross Margin (2020-2027)
3.2.12. Asia Pacific Embolic Protection Devices Consumption by Country
3.2.12.1. China
3.2.12.2. India
3.2.12.3. Japan
3.2.12.4. Indonesia
3.2.12.5. Malaysia
3.2.12.6. Australia
3.2.12.7. South Korea
3.2.13. South America
3.2.14. South America Embolic Protection Devices Consumption Growth Rate (2020-2027)
3.2.15. South America Embolic Protection Devices Consumption, Price and Gross Margin (2020-2027)
3.2.16. South America Embolic Protection Devices Consumption by Country
3.2.16.1. Brazil
3.2.16.2. Mexico
3.2.16.3. Argentina
3.2.17. Middle East and Africa
3.2.18. Middle East and Africa Embolic Protection Devices Consumption Growth Rate (2020-2027)
3.2.19. Middle East and Africa Embolic Protection Devices Consumption, Price and Gross Margin (2020-2027)
3.2.20. Middle East and Africa Embolic Protection Devices Consumption by Country
3.2.20.1. Saudi Arabia
3.2.20.2. Kuwait
3.2.20.3. UAE
3.2.20.4. South Africa
4. Global Embolic Protection Devices Consumption by Product (2020-2027)
4.1. Global Embolic Protection Devices Price by Product (2020-2027)
4.2. Global Embolic Protection Devices Revenue Market Share by Product (2020-2027)
4.2.1. Distal Filter Devices
4.2.2. Distal Occlusion Devices
4.2.3. Proximal Occlusion Devices
5. Global Embolic Protection Devices by Application (2020-2027)
5.1. Global Embolic Protection Devices Price by Application (2020-2027)
5.2. Global Embolic Protection Devices Revenue Market Share by Application (2020-2027)
5.2.1. Coronary Artery Treatment
5.2.2. Carotid Artery Treatment
5.2.3. Others
6. Global Embolic Protection Devices by Procedure (2020-2027)
6.1. Global Embolic Protection Devices Price by Procedure (2020-2027)
6.2. Global Embolic Protection Devices Revenue Market Share by Procedure (2020-2027)
6.2.1. Percutaneous Coronary Intervention
6.2.2. Carotid Artery Stenosis
6.2.3. Saphenous Vein Graft Intervention
6.2.4. Aortic Valve Stenosis
6.2.5. Others
7. Global Embolic Protection Devices by Material (2020-2027)
7.1. Global Embolic Protection Devices Price by Material (2020-2027)
7.2. Global Embolic Protection Devices Revenue Market Share by Material (2020-2027)
7.2.1. Nitinol
7.2.2. Polyurethane
8. Global Embolic Protection Devices by Usage (2020-2027)
8.1. Global Embolic Protection Devices Price by Usage (2020-2027)
8.2. Global Embolic Protection Devices Revenue Market Share by Usage (2020-2027)
8.2.1. Disposable Devices
8.2.2. Re-Usable Devices
9. Global Embolic Protection Devices Consumption by End User (2020-2027)
9.1. Global Embolic Protection Devices Price by End User (2020-2027)
9.2. Global Embolic Protection Devices Revenue Market Share by End User (2020-2027)
9.2.1. Hospitals and Clinics
9.2.2. Ambulatory Surgical Centers
9.2.3. Others
10. Key Companies Profiled
10.1. Abbott Laboratories
10.1.1. Abbott Laboratories Embolic Protection Devices Corporation Information
10.1.2. Abbott Laboratories Embolic Protection Devices Product Portfolio
10.1.3. Abbott Laboratories Embolic Protection Devices Consumption, Price and Gross Margin (2020-2027)
10.1.4. Abbott Laboratories Main Business and Markets Served
10.1.5. Abbott Laboratories Recent Developments/Updates
10.2. Allium Medical Solutions Ltd.
10.3. Boston Scientific Corporation
10.4. Cardinal Health Inc.
10.5. Contego Medical LLC
10.6. Innovative Cardiovascular Solutions LLC
10.7. Edwards Lifesciences Corporation
10.8. Medtronic Inc.
10.9. Silk Road Medical Inc.
11. Marketing Channel, Distributors and Customers
11.1. Marketing Channel
11.2. Embolic Protection Devices Distributors List
11.3. Embolic Protection Devices Customers
12. Market Dynamics
12.1. Embolic Protection Devices Industry Trends
12.2. Embolic Protection Devices Growth Drivers
12.3. Embolic Protection Devices Market Challenges
12.4. Embolic Protection Devices Market Restraints
13. Global Embolic Protection Devices Consumption and Demand Forecast, by Region (2022-2027)
13.1. Global Forecasted Demand Analysis of Microdermabrasion Device, by Regions and Country
13.1.1. North America Forecasted Consumption of Embolic Protection Devices by Country
13.1.2. Europe Market Forecasted Consumption of Embolic Protection Devices by Country
13.1.3. Asia Pacific Market Forecasted Consumption of Embolic Protection Devices by Region
13.1.4. Latin America Forecasted Consumption of Embolic Protection Devices by Country
13.1.5. Middle East and Africa Forecasted Consumption of Embolic Protection Devices by Country
14. Global Embolic Protection Devices Consumption and Demand Forecast, by Device Segments (2022-2027)
14.1. Global Forecasted Consumption of Embolic Protection Devices by Device Segments (2022-2027)
14.2. Global Consumption and Price Forecast by Device Segments (2022-2027)
14.3. Global Forecasted Growth Rate of Embolic Protection Devices by Device Segments (2022-2027)
15. Research Finding and Conclusion
16. Methodology and Data Source
16.1. Methodology/Research Approach
16.1.1. Research Programs/Type
16.1.2. Market Size Estimation
16.1.3. Market Breakdown and Data Triangulation
16.2. Data Source
16.2.1. Secondary Sources
16.2.2. Primary Sources
16.3. Author List
16.4. Disclaimer
Research Methodology
Our research studies are primarily performed in five phases which include Secondary Research, Primary Research, Subject Matter Expert Advice, Quality Check, and Final Review. The process opted for conducting thorough research to make authentic business reports is briefly described below-
Secondary Research-
- Based on the understanding of requirements, we conducted secondary research to identify the Segment specifications, qualitative and quantitative data along with the factors responsible for the growth of the market.
- The secondary sources referred for the study include press releases, company annual reports, and research papers related to the industry.
- Various sources such as industry magazines, trade journals, government websites, and associations were also reviewed for gathering precise analysis on opportunities for business expansions in the market.
- Moreover, quantitative as well as qualitative data were also extracted from paid databases, which included Reuters, Factiva, Bloomberg, One Source, and Hoovers, which proved to be useful for in-depth technical study of the market.
Primary Research-
- The research carried out during the desk research was verified by primary interviews. Primary research was scheduled with a number of industry experts for conducting telephonic interviews, and also our team send questionnaires through their official emails.
- The secondary data collected was then verified by various industry participants which included Segment managers, marketing managers, VPs, CEOs, purchasing managers, subject matter experts.
- An interview with the mentioned participants aids invalidation of our research findings regarding the Segment.
- It helps in the provision of first-hand data on factors such as market size, growth, regional trends, market trends, and competition in the industry. This approach makes our findings precise in order to help our clients in strategic decision-making processes.
Subject Matter Advice-
- The secondary and primary research key findings were then validated by the in-house subject matter experts having extensive experience in the market research industry.
- Specific requirements of the clients were reviewed by the experts to check for completion of the market study. Experts help in channelizing the representation skills of the analyst in terms of providing data that can be easily understood by our customers.
Quality Check-
- The analysis done by the research team was further reviewed to check for data accuracy provided to suit the clients’ specific requirements.
- This revision was done in various phases to check the data authenticity and to remove negligible errors in the final compilation.
Final Review-
- After the quality check, a final review of the report was done to look after the presentation, formatting, and to recheck if all the requirements of the clients were addressed. The next phase remains dispatch of the report to the client.
Enquire Before Purchase
Frequently Asked Questions
Why Choose Market Research Strategy?
We utilize market analysis/information from verified authenticated data sources to scoop accurate research reports
We understand the urgency of our clients and their clients' in the competitive space thus, deliver the report in minimum turnaround
Without further ado, choose us and get instant access to reliable analysis to help you make the right business decisions.
We abide by the information security policy and adheres to keep your private and business information confidential and secure.